Camoteskimab

• CAT Number: I042146
• CAS Number: 2492472-82-7
• Purity: ≥95%

Camoteskimab（Cat No.:I042146）is an investigational monoclonal antibody that targets and inhibits the receptor OX40 (CD134), which is involved in activating T-cells, a crucial component of the immune system. OX40 activation enhances immune responses, particularly in fighting tumors. By blocking OX40, camoteskimab aims to modulate the immune system to reduce inflammation or suppress inappropriate immune activation, depending on the context. It is being studied in clinical trials for its potential to treat various cancers, including solid tumors, with a focus on improving patient outcomes by enhancing immune system activity against cancer cells.